secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001493152-23-038408
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience to merge with NAYA Biosciences in all-stock deal; NAYA shareholders to own 88%
--------------------------------------------------------------------------------

- NAYA shareholders receive 7.33333 INVO shares per NAYA share, totaling ~18.15M shares.
- Combined company to operate as NAYA Biosciences; Dr. Daniel Teper named Chairman & CEO.
- Merger values INVO at $12.4M and NAYA at $90.8M; closing conditions include $5M+ interim PIPE and $5.00/share offering.
- Transaction unanimously approved by both boards, expected to close in Q4 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223038408/0001493152-23-038408-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223038408/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-038408

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer